An average of 24 percent of hip fracture patients age 50 and over die in the year following their fracture. White women 65 or older have twice the incidence of fractures as African-American women. Alendronate is approved for treatment of glucocortocioid-induced osteoporosis in men and women. Risedronate is approved for prevention and treatment of glucocorticoid-induced osteoporosis in men and women. Treatments under investigation include sodium fluoride, vitamin D metabolites, parathyroid hormone, and other bisphosphonates and SERMs.
Medical experts agree that osteoporosis is highly preventable.
However, if the toll of osteoporosis is to be reduced, the commitment to osteoporosis research must be significantly increased. It is reasonable to project that with increased research, the future for definitive treatment and prevention of osteoporosis is very bright. Please contact us to learn more about NOF, National Osteoporosis Prevention Month, or how to become a member. All rights reserved. All rights reserved.